MedTrace Logo

Steroid Use in Non-RSV Bronchiolitis

NCT04221087 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2023-03-21

Study results available
· View outcomes & findings →

Summary

The proposed study is a pilot randomized control trial to determine the efficacy of dexamethasone use in hospitalized children who are less than 2 years of age with non-respiratory syncytial virus (RSV) bronchiolitis admitted to the University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh from February 1 to May 31, 2022. It is hypothesized that the use of standard airway-dose steroids (0.6mg/kg dexamethasone) will improve the clinical outcome of children hospitalized for non-RSV bronchiolitis, which will be evident by decreased length of stay.

Conditions

  • Bronchiolitis, Viral

Interventions

DRUG

Placebos

Sugar water based on same ml dosing of intervention arm drug

DRUG

Dexamethasone Oral

0.6mg/kg/dose - single oral dose administration to intervention arm

Sponsors & Collaborators

  • University of Pittsburgh Medical Center

    collaborator OTHER

  • Allison Williams

    lead OTHER

Principal Investigators

  • Allison E Williams, MD · University of Pittsbrgh, UPMC Children's Hospital of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-03
Primary Completion
2022-12-31
Completion
2022-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04221087 on ClinicalTrials.gov